Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2007, p. 232-242, Vol. 73, No. 1
0099-2240/07/$08.00+0 doi:10.1128/AEM.01608-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Süreyya Dal,
Rita Fischer,
Patricia Patz,
and
Ulrike Gerischer*
Microbiology and Biotechnology, University of Ulm, Ulm, Germany
Received 12 July 2006/ Accepted 23 October 2006
|
|
|---|
|
|
|---|
Here, we focus on Acinetobacter baylyi strain ADP1 (formerly referred to as Acinetobacter sp. strain ADP1), a versatile soil bacterium that has recently been recognized as a distinct species and which differs from close relatives by its unusually high competence for natural transformation (42). A. baylyi uses the ß-ketoadipate pathway, which allows it to grow on a large variety of aromatic compounds. The genes for the protocatechuate branch of the pathway (pca genes) are organized in an operon which includes the downstream qui genes encoding one of the funneling pathways, namely the conversion of the hydroaromatic compounds quinate and shikimate into protocatechuate (7). This large pca-qui operon underlies gene regulation at multiple layers. First, there is the specific induction by protocatechuate which is mediated by the IclR family member PcaU (4, 19, 30). The main effect of this regulator is activation of transcription at the promoter pcaIp upstream of the first pca gene, pcaI. In addition, it also represses the activity of promoter pcaIp by reducing the basal expression level three- to fourfold. Thus, PcaU is an activator/repressor protein with a dual function at the same promoter (39). Furthermore, it has a repressing effect on its own expression (39). The regulatory DNA is a 309-bp intergenic region between the pcaI gene and the pcaU gene facing in the opposite direction. Binding of the purified PcaU protein has been shown to occur to a 45-bp site between the two promoters pcaIp and pcaUp containing a characteristic arrangement of three perfect 10-bp repetitions (34). A related regulator binding sitebut with less perfectly conserved repetitionshas been shown for close relatives of PcaU (12, 21). A higher level of gene regulation affecting pca-qui gene expression (besides other operons) is carbon catabolite repression (6). The presence of certain organic acids, which can serve as substrates for A. baylyi, overrides the effect of the inducer simultaneously present and causes a dramatic reduction of the expression level by 90% during the growth phase. The mechanism leading to this global regulatory effect, which has been documented at the level of enzyme activity and in transcript levels and promoter activity, is unknown. A third layer of regulation is the so-called cross-regulation between the two branches of the pathway. This type of regulation has been described in Pseudomonas putida, where benzoate is consumed prior to p-hydroxybenzoate when offered simultaneously (5, 31). Work by Neidle and collaborators has demonstrated that a similar situation can be found in A. baylyi. Benzoate is used first, and p-hydroxybenzoate is consumed thereafter (16). They were able to show that the expression of the pobA gene encoding the hydroxylase converting p-hydroxybenzoate into protocatechuate is repressed under these conditions. CatM and BenM, transcriptional regulators involved in the specific regulation of benzoate degradation, are necessary to bring about this ordered utilization (3, 14). Whether the central reactions of the pathway are also affected by cross-regulation was unknown.
The current investigation focuses on different aspects of the expression control of the pca-qui operon and the respective regulator gene pcaU. We show that the complex (negative as well as positive) effects of PcaU on promoter pcaIp are intrinsic to this protein because they can be observed in an Escherichia coli background exactly as in Acinetobacter. Contradictory results concerning the expression control of pcaU itself are addressed here by applying different methods. It was observed that the pcaU expression follows the same pattern as the expression of the pca-qui operon. The gene encoding luciferase is introduced as a reporter for promoter activity and allows the very clear observation of expression differences due to the presence of additional carbon sources, which were less clear using ß-galactosidase (6). We are addressing the following questions: whether the amount of PcaU in the cell is important for its effect, and whether overexpression results in lower expression levels at pcaIp. We address cross-regulation of the pca-qui operon by demonstrating that cross-regulation by benzoate (or its metabolites) strongly affects the expression of this operon.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Plasmid and strain construction.
Standard methods were used for plasmid isolation, DNA purification, restriction endonuclease cleavage, ligation, and transformation (35). To create plasmid pAC48, an EcoRI fragment of A. baylyi DNA containing pcaU was gained from plasmid pZR17 and cloned into plasmid pAC16 cut with EcoRI, resulting in pAC41. The lacZ cassette from pKOK6 was introduced using PstI. Plasmid pAC78 was made by using plasmid pAC16 representing a 798-bp NarI fragment from A. baylyi (containing the complete intergenic region between pcaI and pcaU and the 5' area of both genes) cloned into vector pRK415. The source of the Photinus pyralis luciferase gene was plasmid pFW11-luc containing a luc-aad9 cassette. It was cleaved using AccI and SmaI and cloned into pUC19, creating pUC19_luc. From this plasmid the luc-aad9 cassette could be gained as a PstI fragment and cloned into pAC16 linearized with PstI. The resulting plasmid pAC78 (identical to pAC17 except for the reporter gene cassette) contained a transcriptional pcaIp-luc fusion and an incomplete pcaU gene (approximately the 5' third of the gene). Plasmid pAC79 was made like plasmid pAC48, except that the PstI-prepared luc-aad9 cassette (from plasmid pUC19_luc) was used instead of a lacZ cassette. In all cases, the orientation of the cloned fragments was verified by restriction analysis.
A. baylyi strain ADPU12 was made by first inserting the above-mentioned 798-bp NarI fragment cut out from plasmid pZR9 into the BstBI restriction site of plasmid pZR102 (see Fig. 3). The orientation where the directions of transcription of recA and pcaU were opposite to each other was chosen to avoid measuring transcriptional activity from the recA promoter (plasmid pAC21). The lacZ-Kmr cassette from plasmid pKOK6 (SalI cut) was inserted into the XhoI site in the pcaU part of plasmid pAC21 (pAC33). Restriction analysis confirmed the correct orientation of the cassette (see Fig. 3). The plasmid was linearized using BamHI and used to transform A. baylyi strain ADP1. Initial selection was done on LB medium plates with kanamycin (15 µg/ml); subsequently, transfer to LB medium with ampicillin (200 µg/ml) was used to identify a strain that had not incorporated the vector part of plasmid pAC21. Southern blot analysis was employed to verify the correct integration of the construct into the recA gene locus on the chromosome of A. baylyi. Chromosomal DNA of the potential pcaU-lacZ fusion strain was digested with restriction endonuclease BamHI. Hybridization with a recA probe (insert of plasmid pZR102) showed an increase in size of the 3.5-kbp wild-type fragment to 8.8 kbp. Hybridization of HindIII-digested chromosomal DNA with the 798-bp NarI fragment containing the intergenic region between pcaI and pcaU resulted in signals at 3.5 kbp and 1.3 kbp. The 3.5-kbp signal is also observed in the wild type and represents the native pca gene cluster; the 1.3-kbp signal is not present in the wild type and is derived from the newly integrated pcaU-lacZ fusion in the recA gene (data not shown). The new strain was named A. baylyi strain ADPU12. A control strain containing only a lacZ cassette inserted into recA (opposite direction of transcription) verified that there was no detectable transcription under any of the conditions used (6).
![]() View larger version (23K): [in a new window] |
FIG. 3. Carbon source dependence of pcaU gene expression. (A) Transcriptional pcaU-lacZ fusion of A. baylyi strain ADPU12 located on the chromosome remote from the pca genes. The reporter gene cassette is not drawn to scale. (B) A. baylyi strain ADPU12 was grown on mineral medium containing the indicated carbon sources. The concentration of POB when given in addition to another carbon source was 1 mM; otherwise it was 5 mM. Succinate (succ), 10 mM; pyruvate (pyr), 10 mM; succinate plus acetate (S+A), 15 mM each; p-hydroxybenzoate (POB), 5 mM; benzoate, 4 mM; quinate (qui), 5 mM. Protocatechuate was used for induction at 0.1 mM or 1 mM.
|
Strain ADPU53 was made by transforming A. baylyi strain ADP1 with SacI- and EheI-cleaved plasmid pZR430B-luc and selection on mineral medium with succinate and spectinomycin. Colonies were tested for their inability to grow on p-hydroxybenzoate as the sole carbon source. The presence of the luc-aad9 cassette was verified by PCR using primers targeting sequences outside of the DNA that had been used for the transformation (RA-19421, GCCTGCAATGTAATCTTC; and SS-21470, AGGTACCACCAGATCC).
Determination of ß-galactosidase and luciferase activities.
The protocol described by Miller was used to determine ß-galactosidase activity (29). Cells were permeabilized using chloroform and sodium dodecyl sulfate. The standard deviation for replicate assays from the same sample was no more than 2%. To characterize expression levels, we used the reporter gene activity at the onset of the stationary phase (39). The standard deviation between different cultures (same strain, same conditions) was up to 15%. For measurement of luminescence produced by luciferase activity, aliquots of cell suspension were withdrawn from a growing culture and the optical density was measured at 600 nm (OD600). After placing the sample tube with 150 µl of the cell suspension into the luminometer, 150 µl of 2.5x assay buffer (62.5 mM glycylglycin, pH 7.8, 25 mM MgCl2) and then 150 µl of 33 µM D-luciferin (freshly dissolved in water) were added and the luminescence was immediately measured for 15 s using a Flash'n Glow luminometer (Berthold Detection Systems, Pforzheim, Germany). The standard deviation for replicate assays from the same sample was no more than 2%. In all cases, activities of the enzymes were followed throughout the growth phase. The representative value characterizing a particular strain under a certain condition was taken in mid-exponential growth phase. The standard deviation for this value taken for independently grown cultures under identical conditions was up to 30%.
Northern blot analysis.
Cells for preparation of RNA were harvested within no more than 1 min, frozen in liquid nitrogen, and stored at 70°C. The preparation of total RNA and the Northern blot hybridization were done as described previously (7). For signal detection, a Bio Imager Fujix BAS 1000 (Fuji Photo Film Co., Ltd., Tokyo, Japan) was used. The software MacBAS (Fuji Photo Film Co., Ltd., Tokyo, Japan) was applied for quantitative exploitation. Rehybridization of the membranes to ensure application of equal amounts of total RNA with a 16S rRNA gene probe was done as detailed previously (7).
Southern blot analysis.
Total DNA from cells was extracted as described elsewhere (18). DNA was digested with restriction endonucleases and analyzed by Southern blotting and hybridization as described previously (6).
|
|
|---|
with plasmid pAC48 were conducted in LB medium with and without various amounts of protocatechuate (0 to 5 mM), the inducer molecule activating the expression at the pcaIp promoter probably by directly interacting with the PcaU protein. The basal level of expression (70 ± 10 Miller units [MU]) increased when at least 10 µM protocatechuate was present in the medium, as observed earlier for the pcaIp expression in Acinetobacter (39). The highest expression was observed with 1 mM protocatechuate (2,740 ± 410 MU). The induction factor (39-fold) was comparable to Acinetobacter where the pcaIp regulation was also studied with pRK415-based plasmids (18-fold to 94-fold, depending on the carbon source [39]). These results show that (i) PcaU is produced because a protocatechuate-directed induction is detected, (ii) no additional protein besides PcaU is necessary for a concentration-dependent expression at pcaIp (results with plasmid pAC17 containing a truncated pcaU gene and not responding to the presence of protocatechuate [see the next paragraph] served as a control), and (iii) PcaU from A. baylyi and RNA polymerase from E. coli cooperate to allow this induction.
![]() View larger version (9K): [in a new window] |
FIG. 1. Structure of plasmids for the determination of the activity of promoter pcaIp. Overview of the A. baylyi DNA according to the annotation at GenBank (NC_005966; top). The restriction endonuclease sites given are the relevant sites for the construction of the plasmids. The black lines indicate the areas of the DNA drawn in the top of the figure that are contained in the respective plasmids. The reporter cassettes are not drawn to scale.
|
![]() View larger version (11K): [in a new window] |
FIG. 2. Negative and positive effects of PcaU in E. coli. E. coli DH5 with plasmids pAC17 (truncated pcaU; empty squares) or pAC48 (native pcaU; filled diamonds) was grown in LB medium with the indicated concentrations of protocatechuate (PCA). ß-Galactosidase activity was determined at the onset of stationary phase.
|
![]() View larger version (37K): [in a new window] |
FIG. 4. Carbon source dependence of pcaU gene expression. Northern blot hybridization of total RNA (10 µg per lane) grown with the indicated carbon source (succinate, 20 mM; pyruvate, 20 mM). The graphs at the bottom of the figures show the growth curves of the cultures. The time points where RNA samples were taken are indicated by filled diamonds. The bars represent the quantification of the indicated signals in the blot shown above after normalization against the background as well as the 16S rRNA signal. The highest signal was set as 100%. All samples analyzed with one particular probe were blotted on the same membrane and hybridized in the same solution; therefore, the signals can be related to each other quantitatively. (A) Analysis of the pcaU transcript; (B) simultaneous analysis of the pcaU and pca-qui transcript in identical RNA samples. See Fig. 3 legend for abbreviations.
|
To find out if luciferase is a more powerful tool to characterize subtle expression differences, we compared the results of pcaIp promoter activity measurements in equivalent constructs using ß-galactosidase and luciferase from Photinus pyralis (Table 2). We evaluated the PcaU-specific induction, the repression by PcaU, and carbon catabolite repression and found in all cases much more pronounced effects when luciferase was used. The respective induction or repression factors were increased close to 10-fold or more. In particular, the two regulatory effects, repression by PcaU and carbon catabolite repression, display significant repression factors when luciferase is used (30-fold). The use of luciferase also allowed us to demonstrate much more clearly than in the past that the expression at pcaIp still underlies regulation in the absence of the specific regulator PcaU (Fig. 5). A combination of succinate and acetate decreased the basal level of expression by a factor of 10 under the level observed upon growth on pyruvate, a pattern also seen under carbon catabolite repression conditions. LB medium led to the highest level of expression in the absence of PcaU. These results clearly show (i) that luciferase appears more appropriate to characterize smaller expression differences and (ii) that the negative regulatory layers affecting pcaIp expression, like catabolite repression or repression by PcaU in the absence of inducer, appear much bigger when luciferase is used than when ß-galactosidase is used.
|
View this table: [in a new window] |
TABLE 2. Comparison of ß-galactosidase and luciferase as reporter enzymes for the expression at pcaIp
|
![]() View larger version (19K): [in a new window] |
FIG. 5. Regulated expression at pcaIp in the absence of PcaU. A. baylyi strain ADPU59 was grown on mineral medium with the indicated carbon sources. The luciferase activity was taken from cultures in the absence (white columns) or in the presence (gray columns) of 1 mM protocatechuate. See Fig. 3 legend for abbreviations.
|
![]() View larger version (10K): [in a new window] |
FIG. 6. Repression of expression at pcaIp by PcaU increases with increasing pcaU gene copy number. The strains of A. baylyi contained a plasmid-based pcaIp luciferase fusion and between zero and three copies of the pcaU gene. The strains were grown on succinate plus acetate (empty columns), pyruvate (gray columns), or succinate (black columns).
|
![]() View larger version (14K): [in a new window] |
FIG. 7. Effect of benzoate (ben) on the expression at promoter pcaIp (white columns) and pcaUp (hatched columns) measured in A. baylyi strain ADPU47 containing a pcaI-luc fusion or in A. baylyi strain ADPU12 containing a pcaU-lacZ fusion. The cells were grown on mineral medium containing the indicated carbon sources (protocatechuate [PCA], 1 mM). The induced expression on pyruvate plus POB was set as 100%. See Fig. 3 legends for other abbreviations.
|
|
|
|---|
Contradictory results have been described with respect to the carbon source dependence of the regulator gene. The negative autoregulation had been clearly established, but whether or not there was an influence by the carbon sources had been determined with different results using two different plasmid-based reporter systems in A. baylyi (19, 39). Here, we used an approach for measuring the pcaUp activity where the fusion with the reporter gene was situated on the chromosome in a location remote from the native location of the pcaU gene, and therefore it had the lowest possible copy number. (An introduction of the reporter gene into the native pcaU gene was not possible, because this would create a strain without a functional PcaU.) Using this strain, it could be observed that the presence of aromatic compounds to be funneled through the protocatechuate branch of the pathway increased pcaU gene expression considerably (up to sevenfold) over a basal level observed upon growth on nonaromatic substrates. Application of quantitative Northern blot hybridization clearly confirmed the inducible quality of pcaUp. Thus, it is now thoroughly documented that the pcaU gene expression is not only autorepressed but also regulated in a carbon source-dependent manner. Furthermore, a parallel treatment of membranes with samples from identical RNA preparations with probes for pcaU or the pca-qui operon demonstrated that the induction occurs in a time-synchronized way. It thus appears as though the regulatory pattern determined by the pcaU-pcaI intergenic region affects both the promoters located within it and those facing in the opposite directions in the same way. In sum, the pca regulatory region represents a system in which the regulator protein PcaU binds to its binding site located between two promoters, pcaIp and pcaUp, and from this binding site affects expression of both promoters exactly in the same way without contribution by other proteins. This effect can have both a repressing and an activating nature, even though the location of the PcaU binding site with respect to the promoters would infer an activating function (no overlap, but spacing by 11 bp and 4 bp, respectively). The system is reminiscent of the SoxR- and MerR-dependent regulation in E. coli, where two divergent promoters depend on these regulators bound at a single DNA site in the regulatory region and the effect can be both negative and positive (24, 28).
Carbon catabolite repression of the pca-qui operon has been described as a mechanism of gene regulation at a higher level (6). At the level of promoter activity using the lacZ-based reporter construct, the effect could be demonstrated but at a fairly low level (4.7-fold repression). When luciferase was used instead of ß-galactosidase to determine promoter activity upon carbon catabolite repression, a much higher repression factor could be determined (30-fold). The transcriptional nature of this regulatory mechanism is well documented by this approach. The molecular mechanism responsible for this new type of carbon catabolite repression is still unknown.
In the course of the identification of PcaU, complementation experiments had indicated that the expression of the pca gene products is lower when increased amounts of PcaU are present in the cell (19). Here, results are presented that strongly indicate such a mechanism. The basal level of transcription at pcaIp is lowest when three copies of pcaU are present in the cells and highest when no pcaU is present. The additional copies of the gene must cause a higher level of PcaU. The mechanism leading to a reduction of expression may have to do with a higher occupancy of the PcaU binding site at higher concentrations. Taken together with the data presented above proving the differential expression of pcaU, it is strongly indicated that the PcaU levels in the cells differ and furthermore that different PcaU concentrations cause repression at pcaIp to be more or less pronounced. Under inducing conditions, overexpression of PcaU also causes a decrease of expression (19), indicating that there must be an optimal concentration of PcaU for the highest possible induction.
Cross-regulation between the two branches of the pathway has been shown earlier with respect to the pobA promoter, which is repressed ifin addition to the inducer of the pobA gene (p-hydroxybenzoate)metabolites of the catechol branch of the pathway are present. cis,cis-Muconate could be identified as the regulatory active compound (3). Here, it could be shown that this type of regulation also applies to the pca-qui operon and therefore to the regulation of expression of the central reactions. The presence of a substrate of the parallel branch of the pathway (benzoate) strongly repressed the expression at pcaIp despite the presence of the inducer. Furthermore, the same repression pattern was observed at the promoter pcaUp. Thus it is established that the repression of the enzymes for p-hydroxybenzoate degradation by metabolites of the parallel branch is a mechanism of transcriptional regulation affecting all promoters involved in the expression of the respective enzymes, namely pcaIp, pcaUp, and pobAp. Cross-regulation seems to be an important mechanism, as it creates an order of degradation for carbon sources accessed by the two branches of the ß-ketoadipate pathway and is therefore established in multiple promoters. It remains to be seen whether or not the promoters of other funneling pathways preparing alternative aromatic compounds for the degradation through the protocatechuate branch also underlie this cross-regulation.
Concerning the molecular mechanism responsible for the repression, it is obvious that one might speculate that regulatory proteins that do bind metabolites representative of the benzoate/catechol branch could also affect the promoters necessary for p-hydroxybenzoate degradation. In fact, it was shown that the regulators BenM and CatM do bind to a 291-bp DNA fragment from the pcaU-pcaI intergenic region, and the binding was stronger in the presence of cis,cis-muconate. A putative binding site for this interaction was identified directly downstream of the transcriptional start site of the pcaU gene (3). In contrast, there was no binding of CatM or BenM in the pob regulatory DNA. In addition, deletions causing disruption of both the catM gene and the benM gene allowed the simultaneous degradation of substrates of both branches of the pathway (benzoate and p-hydroxybenzoate). CatM and BenM are LysR-type proteins positively regulating genes involved in benzoate degradation (14). These results clearly established the role of BenM and CatM in the cross-regulation, but the mechanism remained unclear. Brzostowicz et al. speculated that the binding of CatM or BenM a few base pairs downstream of the pcaU transcriptional start site might disturb the binding of PcaU to its binding site and therefore prevent high-level expression of the pca genes (3). Since pcaK encoding a transport protein bringing external p-hydroxybenzoate into the cells (PcaK) is part of the operon, it was thought that this transport might not happen at levels high enough to allow an induced pobA expression. This hypothesis is based on the assumption that another protein known to transport p-hydroxybenzoate in addition to PcaK, namely VanK, is also repressed under the conditions of cross-regulation (8). It was unclear what the effect of CatM and BenM binding in the pca intergenic region was. In the current investigation, we could show that the expression at both promoters, pcaUp and pcaIp, was as low as in the absence of inducing compounds. Due to the divergent nature of the pca intergenic region with the PcaU binding site centrally located, factors influencing PcaU binding may affect expression in either direction, which is supported by results presented in this paper. Following the suggestion that the binding site for CatM and BenM is located within the DNA encoding the pcaU RNA and thus 44 bp away from the PcaU binding site, it is unlikely that there is a direct disturbance between the two regulatory proteins. More likely is a physical hindrance of RNA polymerase binding to promoter pcaUp or a blocking of elongation of transcription. The result would be a strong decrease in the level of PcaU not sufficient to occupy the PcaU binding site in a way necessary for an efficient activation of pcaIp. Thus, binding of BenM and CatM upstream of the pcaU gene is very likely the molecular mechanism leading to the cross-regulation phenotype at promoter pcaIp. In contrast, the mechanism leading to cross-regulation of pobA expression is less obvious.
The absence of PcaU leads to an increased basal level of expression of the pca-qui operon as shown here and previously (39). This level is high enough to allow growth of cells with a truncated pcaU gene. Based on this observation, it can be assumed that under conditions where pcaU expression is repressed by cross-regulation, the pca-qui operon will be expressed at increased levels and thus PcaK should be present at levels high enough to bring p-hydroxybenzoate into the cells. Even under conditions where PcaU is present in the cells at wild-type levels, PcaK levels should be sufficient to bring enough p-hydroxybenzoate into the cells to allow efficient induction of pobA expression as shown using an Acinetobacter strain with a lacZ cassette inserted into the pobA gene (3). Since this strain does not convert p-hydroxybenzoate into protocatechuate, the inducer of the pca-qui operon is not created, but despite this the strain was successfully used to monitor effects of cell-internal p-hydroxybenzoate. Furthermore, results have been reported describing strains without PcaK and VanK that can grow on p-hydroxybenzoate like the wild type, indicating that these two transporters are not a necessary requirement for p-hydroxybenzoate uptake (8). In Pseudomonas putida a benzoate-mediated repression of pcaK expression by the regulator BenR, and furthermore a relief from the repression in a benR mutant as detected by measuring p-hydroxybenzoate transport, could be demonstrated (36). In contrast to A. baylyi, in this organism the pcaK gene has its own promoter region. We assume that BenR (an XylS family member) does not have a direct role in this repression.
If a repressed transport is not the mechanism for repression of pobA expression by cross-regulation, then what is a possible mechanism? Here, we evaluated the possibility that PobR senses the presence of protocatechuate by looking at PobR-dependent pobAp regulation in E. coli. PobR did not cause a reduction in p-hydroxybenzoate-dependent activation of pobAp when tested in E. coli in the presence of protocatechuate. This indicates that PobR is not integrating multiple signals like the level of protocatechuate in addition to the level of p-hydroxybenzoate. In contrast, there must be a different mechanism of bringing this information to the pobAp promoter which needs to be identified. Another possibility would be that PcaU, the natural sensor of protocatechuate, also binds to the PobR binding site. This scenario is convincing, since there is high similarity at the level of the proteins PobR and PcaU as well as at the level of their binding sites. A first indication that this is not the case came from gel retardation assays testing the purified PcaU protein for binding to the pobR-pobA intergenic DNA. These experiments could not detect any binding of PcaU to the PobR binding site (unpublished observation). Of course, the affinity of this interaction may be very low. Other possibilities would be (i) formation of a hybrid complex of PcaU and PobR monomers at the PobR binding site when protocatechuate is bound by PcaU, which does not allow a functional transcriptional activation, (ii) direct binding of CatM or BenM to a DNA site outside of the one tested earlier from which they may influence pobA expression, or (iii) the involvement of factors that have not been identified yet. These are models that need to be addressed.
To summarize, the mechanisms of cross-regulation, including regulation by a downstream metabolite (protocatechuate) at promoter pobAp, remain unknown, but one possible mechanism can now be excluded, namely the direct sensing of the repressing metabolites by PobR. Cross-regulation is probably not an uncommon mechanism for achieving the most efficient fine-tuning between different pathways. It was described recently between the pathways for biphenyl and salicylate degradation in Pseudomonas pseudoalcaligenes (15).
The results presented here help to unravel the complexity of regulation of the central pca-qui operon as well as of promoters influenced by cross-regulation (Fig. 8). It is intriguing that there is just one mechanism of activation of gene expression, whereas there are multiple mechanisms of repression, which make sure that gene expression is low under a variety of conditions and therefore help the organism to be highly economical with the available resources.
![]() View larger version (12K): [in a new window] |
FIG. 8. Schematic presentation of the regulatory levels known to contribute to gene expression within the protocatechuate branch of the ß-ketoadipate pathway of A. baylyi (the pobS gene located between pobR and the qui genes were not included in the scheme). The thick horizontal arrows represent promoters; thus, the double arrows stand for two divergent promoters. The vertical lines demonstrate regulatory mechanisms affecting positively (bottom) or negatively (top) the respective promoter. POB, p-hydroxybenzoate; PCA, protocatechuate.
|
The technical assistance by Iris Steiner is gratefully acknowledged.
Published ahead of print on 3 November 2006. ![]()
Present address: Universitätsfrauenklinik und Poliklinik, University of Ulm, Ulm, Germany. ![]()
Present address: Ratiopharm GmbH, Ulm, Germany. ![]()
Present address: Lilly Deutschland GmbH, Bad Homburg, Germany. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»